User blogs
4CH Mobile DVR,G-Sensor,GPS,3G, WiFi, SD
This mobile digital
video recorder has 4-channels and records 720 x 480 (D1) resolution at
30 frames per second — on all four video channels. This compact
4-channel DVR is only about an inch thick. This versatile unit can be
installed under vehicle seats, below the radio compartment or in the
trunk.mobile dvr 4ch
Features H.264 video compression to maximize recording and consume less
space on the SD card. The unit also records in AVI files, which makes
video offloading and playback easy as well. This device features 4 alarm
inputs, and two alarm outputs for event-triggered recording, such as
bus doors opening or closing, activation of signal lights, increased
speed, sirens and more.
The DVR is equipped with an easy-to-use on
screen display (OSD). This compact mobile DVR also features a tamper
enclosure that locks over the top of it to prevent unwanted access to
the device — for added security.
* SD card is not included.
H.264 Compression Mode, stream recording, 4 CH real-time Standard
Definition camera input 2CH AHD High Definition + 2CH Standard
Definition mixed input. / 4CH Analog Standard Definition Camera input.
Real-time HD Video Recording, 720P/D1/HD1/CIF for Optional, Adjustable Frame Rate Quality.
Professional Power Design for all kinds of Vehicles, 8-36V DC; Wide
Voltage, Over-load, Over-voltage, Short Circuit, Reverse Protection,
Suitable for all kinds of vehicles.
Support DC 12V output, it can offer power for cameras, mini monitor and some peripheral devices.
SD card Data record storage (2 SD Cards, Each maximum support 128GB SD card.)
Vibration and dust resistant
Watchdog “Abnormal” will trigger a restart protection function. Helps protect device and video.
Exclusive DVR special file system technology, helps ensure the integrity of the data.
Power-off protection function. Unique technology ensures the integrity of recording when a power failure occurs.
Time-lapse Video Recording Function (Highest support long delay time 24 hours.)
Linux 3g 4g Mobile Dvr With Gps Monitoring System
1. The MDVR has a G sensor?
Answer: yes, SDM605 supports G-sensor
2. The MDVR can send data and or events over 3G?
Answer:Yes, the DVR with 3G function will send the live data and video over 3G
3.The MDVR can be set to send all video on storage card to a web server if the MDVR is connected to WIFI?mobile dvr 3g gps
Answer: Yes, there are 3 ways for you to get the videos on the storage card. 1st, you just download the video directly from the SD card or harddisk. 2nd you could remotely download the videos or GPS tracking through our Clients software. 3rd way, you could download the videos by a certain schedule through wifi network.
If you're interested in the Linux
3g 4g Mobile Dvr with Gps Monitoring System, welcome to contact our
factory. As one of the professional China manufacturers and suppliers in
this field, our company has passed the CE certification. Please be free
to get the high-quality solutions and system with us.
Hot Tags:
Linux 3g 4g Mobile Dvr with Gps Monitoring System, manufacturers China,
factory, suppliers, company, system, solutions, high-quality, CE
certification
Isle Casino Pompano looks to revive fast-paced game
Isle Casino
Racing Pompano Park is the latest gambling mecca looking to install the
centuries-old court game, and spectators bet on the outcomes of
head-to-head matches.
But the plan would mean phasing out the
casino’s long-time harness racetrack in favor of a jai alai fronton that
seats up to 300 people, suggests the casino’s parent, ElDorado Resorts,
in a proposal filed with the City of Pompano Beach.no deposit bonus casinos
The planned move comes after decades as a horse racing venue in the
winter months. On its website, Isle Casino says it has been “Home to
World-Class Standardbred Racing since 1964.”
It is unclear why
Eldorado, of Reno, NV., and its joint venture partner, Cordish Companies
of Baltimore, has elected to install jai alai, a sport that has been on
the wane in South Florida for decades. ElDorado representatives did not
respond to a request for comment. But in an email late Friday to the
South Florida Sun Sentinel, Cordish CEO David Cordish suggested that
both sports could co-exist at Pompano Park.
Whatever emerges, there
is a strong notion among jai alai promoters that their sport is
undergoing somewhat of a revival in South Florida. The sport, executives
say, which suffered a dramatic decline in popularity since a strike in
the early 1990s, is showing signs of a comeback.
Magic City Casino
in Miami just started its second jai alai season after closing its
greyhound dog racing operation in the wake of a statewide constitutional
amendment halting the sport. Gulfstream West, formerly known as Calder
Race Course, which dropped horse racing, is starting its second season
Aug. 1. Casino Miami starts a new season in December. And Dania Beach
Jai Alai, the stalwart of the sport in South Florida for decades, was
part of a recently completed multimillion dollar renovation of The
Casino at Dania Beach.
“Our ownership group and management firmly
believe that jai alai can be re-energized within the South Florida
community,” said Arnaldo Suarez, general manager of The Casino at Dania
Beach. “It’s an icon of the city. It has brought thousands of people to
our fronton."
A much faster version of racquetball, jai-alai
originated in the Basque region of northern Spain centuries ago. To
succeed on the court, players need extraordinary hand-eye coordination
and quick reflexes. The ball, called a pelota, travels up to 150 mph.
Players may not hold the ball, and use a curved basket called a cesta
for catching and throwing, which is continuous.
Everett Casino Generates $4.2 Million In Tax Revenue In First Week
In
the first eight days that Encore Boston Harbor was open, gamblers
wagered more than $93.5 million on the slot machines alone at the
Everett casino and the Wynn Resorts operation counted $16.79 million in
total revenue, or more than $2 million a day.no deposit bonus
More
than half of the eight days worth of revenue, $9.12 million, was
generated by the resort casino's 3,158 slot machines. Those machines
returned about 90.25 percent of the $93.5 million that players put into
them as winnings and held back 9.75 percent for the House, the
Massachusetts Gaming Commission reported in its monthly revenue roundup.
The casino's 242 table games brought in another $7.67 million in
revenue for Encore between its June 23 grand opening and the end of
June.
Last week, Encore Boston Harbor officials touted the Everett facility's smooth opening and said everything was operating well at the $2.6 billion resort gambling palace."So far, so good," Encore Boston Harbor President Robert DeSalvio said last week on WGBH's Greater Boston. "However, I will tell you that it takes a while to ramp up and build these properties up to full potential — you have to build a database — so for us, there's an expectation that it doesn't come automatically but it will come over time."
Though he did not disclose the casino's revenues for its first eight days, DeSalvio said it is "way too early to tell" whether Encore Boston Harbor will meet its expectation of $800 million in annual revenue.
The first week-plus of action at the Greater Boston resort casino generated about $4.2 million in tax revenue for the state, but coincided with the second-worst month on record for the state's first full-scale casino, MGM Springfield. While Encore counted $16.79 million in revenue in eight days, MGM Springfield took in just more than $19.95 million in revenue over the full month of June.Gamblers put $174.75 million into MGM's slot machines last month, generating $14.7 million in revenue for the casino. In June, MGM Springfield's slots paid out at a higher rate than Encore Boston Harbor's machines. In Springfield, the machines returned 91.59 percent of money wagered to players while Encore's slots returned 90.25 percent.
With another $5.26 million in revenue from table games, June represented the worst revenue month for MGM Springfield since January (19.7 million) and only the second full month since opening last August that the casino did not earn at least $21 million from gaming.
Is someone spying on me through my cell phone camera? It's absolutely possible to look at a person through the camera on your phone. But first, you must ask yourself, “WHY would anyone want to look through my camera?” Are you really that important? If you are, then you likely have advisors that have already answered this question for you. If someone has had access to your phone for 5–7 minutes, they could have downloaded spyware. The spyware could be used to access any of the features on your phone. It could be the camera, the GPS, your text messages, your contact list, etc.
In fact things can be accessed remotely that cannot be accessed with the phone actually in your hand. For example, even your deleted text messages are accessible remotely but you cannot access them with your phone actually in hand. This spyware is purposely made to be hidden. Usually it requires wiping the phone back to the factory settings. Do not back it up first though it you'll simply back up the spyware and it will be reinstalled. This type of spyware requires access to the phone and is actually “touching” the phone to spy on you. It could be a spouse, a parent, a boss, etc. The other possibility, the scarier yet very real method of accessing your phone doesn't need to ever touch your phone at all. All that is needed is a phone number.
This method access the Cameron through a small glitch in the network. The SS7 (Signal System Number 7) is used in this method. Every country is aware of this “glitch.” Can it be fixed? Do we want it fixed? NSA Operation Dropout Jeep has been active longer than most are aware. There's truly NOTHING that is not accessible. If you are important enough, you can assure yourself that there is a person or team of persons who are paid to collect Intel on you through SIGINT, COMINT and many forms of ELINT. This is signal, communications and eiectronic intelligence. Again, if you are important enough to be spied on, you're not getting your answers on this forum. I won't go much deeper here as it’s not necessary. How do you know if your camera is being accessed remotely?
Regardless if it's through a downloaded spyware program
or much more intelligent means, the battery on your phone is powering
your camera. You might notice your phone is getting hot when just
sitting there. Your battery isn't lasting long. You might catch your
phone making an unusual sound or a light flicker when it's not even
being touched. These are reasonable signs that there is something you're
not aware of running in the background. If the camera is accessed, it
can be used to look through in real time or more commonly, it will be
set to take a picture in set intervals. This will save the battery. It
may be set to take a picture every 1 second, every 3 seconds, every 60
seconds any other increment.https://www.ttspy.com/the-easiest-fastest-way-to-hack-into-someones-iphone.html
The adidas Yeezy Boost 350 V2 has been going through an identity crisis but now things have finally been straightened out thanks to adidas Originals. Is it Steel Grey? Stealth Grey? Steeple Gray? Beluga? Here’s the answer.
Kanye West’s latest release from The Three Stripes, as expected, has the Internet in a frenzy. The V2 Yeezy Boost 350 is set to release this week but for the past few months it’s been a guessing game as to what the name of the shoe would actually be. It started as Stealth Grey, then became Steel Grey, but now, thanks to the video below from adidas Originals, we know that the official colorway of the first Yeezy V2 (BB1826) release is a combination of Steeple Gray, Beluga and Solar Red Primeknit yarns. The video also shows an internally reinforced toebox. For those of you looking to skateboard in your Yeezys, this should come as good news. Now, how are you going to get your hands on a pair of the adidas Yeezy Boost 350 V2 come September 24th?buy Yeezy 700 Static with best price
If you need more info on Yeezy releases, specifically how they have sold on the secondary market, check out this post to prepare for this week’s release.
The testosterone undecanoate was originally discovered by Bayer Pharma, which sold the licence for the development to Endo Pharmaceuticals in the US.
Endo received approval for Aveed from the US Food and Drug Administration (FDA) for treatment of hypogonadism in adult men in March 2014.Hypogonadism is a condition that involves the body’s sex glands producing fewer or no hormones due to the reduced functional activity of the gonads. The disease, depending on the degree of severity, can result in partial or complete infertility.
Aveed contains testosterone undecanoate, which is an ester of testosterone. The drug can be administered using androgen replacement therapy (ART). The testosterone hormone is primarily responsible for the normal growth and development of the male sex organs and for the maintenance of secondary sex characteristics.
The FDA approval for Aveed was based on the results obtained from a Phase III clinical study conducted for 84 weeks. The single-arm, open label, multicentre clinical study enrolled 130 hypogonadal adult patients who had an average age of 54 years with morning serum total testosterone concentrations <300 nanograms per decilitre (ng/dL). The patients were administered with Aveed 750mg injection at the initiation of the therapy, at four weeks, and then every ten weeks thereafter.
The primary endpoint of the study was the percentage of subjects with average serum total testosterone concentration (Cavg) after the third Aveed injection. The secondary endpoint included the percentage of subjects with maximum total testosterone concentration (Cmax) above three predetermined limits greater than 1,500ng/dL.
The results of the study demonstrated that patients treated with Aveed showed increased mean serum testosterone levels and maintained them up to ten weeks at steady state. The study also found that about 94% of the patients administered with Aveed maintained a Cavg within the normal range between 300ng/dL and 1,000ng/dL. 117 patients out of 130 completed the study procedures through Week 24 after the third Aveed injection and were included in the evaluation of testosterone pharmacokinetics.
The US Food and Drug Administration (FDA) has approved testosterone undecanoate (Jatenzo) for the treatment of men with hypogonadism. The oral capsule therapy is designated for men with low testosterone levels due to specific genetic disorders or pituitary gland-damaging tumors.
However, the FDA approval does not designate undecanoate for age-related hypogonadism—in which men’s testosterone levels are in decline due to aging—due to the therapy’s benefits not outweighing its risks in that use.Testosterone decanoate powder
The efficacy of Jatenzo, from Clarus Therapeutics, was demonstrated in a four-month clinical trial in which a 237 mg oral drug was administered twice daily to 166 men with hypogonadism. Patient doses were adjusted either downward or upward to a maximum of 396 mg twice daily based on current testosterone levels.
Investigators reported that 87% of therapy-treated men achieved the primary endpoint of an average normal-range testosterone level. Common adverse effects, which occurred in at least 2% of patients in the trial included headache, red blood cell count increases, decreases in high-density lipoprotein cholesterol, high blood pressure, and nausea.
Testosterone undecanoate’s label will be marketed with a boxed warning stating it can cause risen blood pressure, thereby increasing heart attack, stroke, and cardiovascular death risks. Physicians are advised to periodically monitor their patients’ blood pressure during treatment.
With the approval, testosterone undecanoate becomes the second testosterone product to carry that warning. The FDA requires all testosterone product manufacturers to perform post-marketing blood pressure trials to better address the products’ risks.
Hylton V. Joffe, MD, MMSc, director of the FDA’s Center for Drug Evaluation and Research’s Division of Bone, Reproductive and Urologic Products, said that testosterone undecanoate’s oral administration makes it an “important addition to current treatment options available” for the patient population. Up until now, most testosterone products are administered subcutaneously or intravenously.
“But it’s important to emphasize that this drug should not, like other testosterone treatments, be used to treat older men with ‘age-related hypogonadism’,” Joffe said in a statement. “The benefits of testosterone therapy, including Jatenzo, have not been established for this use, and Jatenzo’s effects on raising blood pressure can increase the risks of heart attack, stroke and cardiovascular death in this population.”
Some aging men might have perked up at the news that the U.S. Food and Drug Administration (FDA) approved an oral testosterone treatment for hypogonadism, or low gonadal testosterone production. After all, with advertisements bombarding them with claims that attribute all of their ills to “low T” and urge them to “ask their doctor” about it, aging men might think it’s high time for a pill to pop instead of dealing with a messy gel.Testosterone decanoate benefits
Unfortunately for them, the agency says that the newly approved drug, Jatenzo (testosterone undecanoate; Clarus Therapeutics) isn’t for age-related testosterone declines. Instead, it’s intended to treat people who have hypogonadism because of less common causes, such as tumors of the pituitary gland or Klinefelter’s syndrome. This form of testosterone was previously approved as an injectable, Aveed (Pfizer).
The pituitary gland sends messages to the gonads that regulate
release of hormones, and tumors can turn the volume on these messages
inappropriately up or down . Klinefelter’s syndrome is the name given to
the suite of traits that result when someone carries a Y chromosome
along with two X chromosomes. One of the features of Klinefelter’s can
be smaller-than-average testes that produce low levels of testosterone.
Having this condition is associated with increased risks for obesity,
insulin resistance and mortality, which is related to why the FDA views
the benefits of Jatenzo as outweighing risks for this population.
The drawback of Jatenzo, the FDA said in a statement, is that as with
all testosterone treatments, risks increase for higher blood pressure,
which in turn is a risk for cardiovascular disease and death. For people
who have pituitary tumors or Klinefelter’s syndrome, it’s possible that
the benefits of the drug outweigh these risks. For older men
experiencing typical effects of aging, however, it is not, the FDA
concluded. About a third of men in older age might have hypogonadism.
The cardiovascular risk is sufficient that the drug label will carry a boxed warning, as does Aveed, which is available only through the FDA’s tightly controlled risk evaluation and mitigation strategy. The agency urges that clinicians keep each individual patient’s cardiovascular risk in mind and ensure that their blood pressure controlled when on the drug. People with the conditions that are considered indications for taking Jatenzo often are already using some other form of testosterone (injection or skin patch), so their risk may not vary with a switch to an oral pill. Almost 9 out of 10 of the 166 participants in the 4-month trial of Jatenzo saw their testosterone levels rise to normal range while taking the drug.